Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis
Tóm tắt
We proposed a method of regional assessment in patients with rheumatoid arthritis. The utility of this method was demonstrated by assessing drug efficacy in patients who received infliximab (n = 31) or tocilizumab (n = 6). Joints were divided into four regions: upper/large, upper/small, lower/large, and lower/small. The total joint index was calculated as follows: the sum of tender and swollen joint counts divided by the number of evaluable joints in each region. At the baseline, the total joint index of the upper/small region was the lowest and that of the lower/large region was the highest compared with other regions. The change in the total joint index from the baseline to the 30-week point (Δ) did not differ among the four regions. There were significant close relations of Δ between the upper/small and the upper/large region and between the lower/small and the lower/large region. This method allows us to focus on a specific region and to compare and contrast among them.
Tài liệu tham khảo
Dougados M (2007) Can we combine patient’s and doctor’s perspective when assessing rheumatoid arthritis disease activity? J Rheumatol 34:1949–1952
Duff GW (1994) Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rheumatol Suppl 100:9–19
Badolato R, Oppenheim JJ (1996) Role of cytokines, acute-phase proteins and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum 26:526–538
Chen X, Oppenheim JJ, Howard OMZ (2004) Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medical components. Cell Mol Immunol 1:336–342
Christodoulou C, Choy EH (2006) Joint inflammation and cytokine inhibition in rheumatoid arthritis. Clin Exp Med 6:13–19
Prevoo MLL, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM (1995) Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48